Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary(®)): Results of a Nationwide Dose Conversion Survey

por Hauser, Robert A., Banisadr, Ghazal, Vuong, Kara, Freilich, David, Fisher, Stanley, D'Souza, Richard
Publicado 2021

Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation

por LeWitt, Peter, Ellenbogen, Aaron, Burdick, Daniel, Gunzler, Steven, Gil, Ramon, Dhall, Rohit, Banisadr, Ghazal, D'Souza, Richard
Publicado 2023

Geminin-Deficient Neural Stem Cells Exhibit Normal Cell Division and Normal Neurogenesis

por Schultz, Kathryn M., Banisadr, Ghazal, Lastra, Ruben O., McGuire, Tammy, Kessler, John A., Miller, Richard J., McGarry, Thomas J.
Publicado 2011

IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial

por Hauser, Robert A., Espay, Alberto J., Ellenbogen, Aaron L., Fernandez, Hubert H., Isaacson, Stuart H., LeWitt, Peter A., Ondo, William G., Pahwa, Rajesh, Schwarz, Johannes, Stocchi, Fabrizio, Zeitlin, Leonid, Banisadr, Ghazal, Fisher, Stanley, Visser, Hester, D’Souza, Richard
Publicado 2023